MHMingyang Hou

Mingyang Hou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mingyang Hou has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Zhiyong Huang

    School of Microelectronics and Communication Engineering, Chongqing University, Chongqing, 400044, China; Key Laboratory of Dependable Service Computing in Cyber Physical Society (Chongqing University), Ministry of Education of China, Chongqing University, Chongqing, 400044, China

    16 shared publications
  • Zhi Yu

    School of Microelectronics and Communication Engineering, Chongqing University, Chongqing, China

    15 shared publications
  • Yan Yan

    Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

    13 shared publications
  • Yushi Liu

    Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China

    12 shared publications
  • Xiaoyu Li

    Bioengineering College, Chongqing University, Chongqing, China

    8 shared publications
  • Jiahong Wang

    The Second Medical Center, Health Management Institute, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China

    5 shared publications

Latest Publications

  • Bridging teacher–student representation domains for manifold-aware knowledge distillation

    by Shuai Miao, Zhiyong Huang, Daidi Zhong, Zhi Yu, Mingyang Hou, Penghao Jia, Yan Yan, Yushi Liu

  • Open Access

    Prediction of Blood Transfusion Need and Dose in Patients With Upper Gastrointestinal Bleeding: Retrospective Multicenter Prediction Model Study

    by Xiaoyu Li, Yuqin He, Mingyang Hou, Zhi Yu, Shuai Miao, Zhiyong Huang, Min Yang

    Background: Transfusion thresholds in upper gastrointestinal bleeding are debated; hemoglobin cutoffs of 70‐80 g/L are widely cited yet inconsistently applied. Common risk scores offer limited individualized guidance and rarely provide calibrated, interpretable predictions for transfusion decisions. Objective: This study aimed to develop and validate a two-stage, clinically constrained gradient-boosting framework (Medically Constrained Gradient Boosting [MCGB]) that predicts transfusion need and estimates transfusion dose with quantified uncertainty and to implement a prototype recommendation system for clinical use. Methods: We analyzed a retrospective multicenter cohort of 849 adults with endoscopically confirmed upper gastrointestinal bleeding admitted to 3 hospitals in Chongqing, China (January 2019 to August 2025). Predictors available before the transfusion decision included demographics, first recorded vital signs, initial laboratory indices, and clinician-adjudicated etiology. Stage 1 used a calibrated classifier with prespecified monotonic constraints and stability-screened, clinically justified interactions. Stage 2 modeled transfusion dose via quantile predictions with conformal adjustment to generate 95% prediction intervals. Performance was assessed using a cross-site hold-out design. Overall, 2 hospitals were used as the development cohort, within which stratified 5-fold cross-validation was performed for model development, hyperparameter tuning, interaction screening, and calibration. The remaining hospital was held out as an independent test cohort for final evaluation. Hospital-wise alternating external testing was further conducted as a supplementary robustness analysis to assess performance stability across institutions. Classification performance was evaluated using discrimination metrics (area under the receiver operating characteristic curve and area under the precision-recall curve), calibration metrics, and decision-curve analysis; regression performance was evaluated using R ², mean absolute error, and prediction-interval coverage. A graphical user interface was implemented to enable clinicians to input patient data and obtain calibrated predictions of transfusion probability and corresponding dose recommendations. Results: MCGB achieved strong discrimination and good calibration across subgroups (area under the receiver operating characteristic curve=0.97 and area under the precision-recall curve=0.91). At a reference probability threshold of .50, sensitivity, specificity, and F 1 -scores were 0.99, 0.87, and 0.85, respectively, providing a representative operating point for comparison. For dose prediction among transfused patients, MCGB achieved R ² of 0.95 and mean absolute error 0.04; 95% prediction-interval coverage was 0.94, indicating accurate point estimates with reliable uncertainty quantification. The software prototype further demonstrated feasibility of real-time decision support at the bedside. Conclusions: MCGB provides calibrated, interpretable predictions of transfusion need and individualized dose in upper gastrointestinal bleeding and may support bedside decision-making and blood-bank planning, with a prototype interface demonstrating potential for clinical deployment. External validation in additional settings is warranted to confirm generalizability.

  • Integrating visual and language cues via state space models for medical image segmentation

    by Mingyang Hou, Zhiyong Huang, Daidi Zhong, Zhi Yu, Xiaoyu Li, Jiahong Wang, Yan Yan, Yushi Liu, Min Yang

  • Open Access

    Dyssynergia phenotypes in obstructed defecation: insights from Fecobionics assessment

    by Wenbo Li, Mingyang Hou, Yi Li, Houde Yu, Yuqin He, Haibin Yao, Shili Xiao, Kaijun Liu, Xin Fu, Liangzhi Wen, et al.

    Objective: Obstructed defecation syndrome (ODS) is a chronic constipation subtype. Conventional tests are limited by non-physiological conditions and poor correlation with symptoms. This study investigated anorectal dynamics and dyssynergia phenotypes in patients with ODS using Fecobionics. Methods: This study was designed as a prospective observational study including 10 control subjects and 25 patients with ODS. All measurements were performed according to a predefined protocol. All patients with ODS underwent clinical evaluation, anorectal manometry (ARM) and defecography. Fecobionics recorded anorectal pressures, sensation and expulsion performance. Expulsion dynamics were further analysed using preload–afterload diagrams to characterise dyssynergia subtypes. Results: Compared with the control group, the ODS group showed prolonged expulsion time (76 (23–120) vs 18.7 s (10.6–34), p<0.01), reduced effective propulsive force (P_delta) (26.2 (8.6–35.9) vs 48.2 cmH₂O (32.5–88.0), p<0.01), increased number of contractions (7 (4–14) vs 2.5 (1.3–3.8), p<0.01) and higher paradoxical contraction rates (71% (50–100) vs 0% (0–44), p<0.01). ARM during attempted evacuation (push) demonstrated lower anal relaxation rates in the ODS group (16% (12–37) vs 36% (27–44), p<0.03). Correlation analyses demonstrated that impaired Fecobionics metrics were associated with greater symptom burden. Three dyssynergia phenotypes were identified: multiple simultaneous contractions, insufficient or delayed anal relaxation and persistently elevated outlet pressure. Conclusion: Fecobionics enables integrated and physiologically relevant assessment of anorectal function and identifies distinct dyssynergia phenotypes in ODS, reflecting heterogeneous mechanisms of outlet obstruction with implications for individualised management. Study registration: ChiCTR2300078807.


  • Eliminating domain-related confounding factors in cross-domain one-shot medical image segmentation via causal inference

    by Mingyang Hou, Zhiyong Huang, Daidi Zhong, Zhi Yu, Xiaoyu Li, Jiahong Wang, Yan Yan, Yushi Liu


  • Enhancing Radiography-Report foundation model via Multi-View masked contrastive learning

    by Xiaoyu Li, Daidi Zhong, Zhiyong Huang, Shiwei Wang, Zhipeng Liu, Zhi Yu, Mingyang Hou, Jiahong Wang, Yan Yan, Yushi Liu


  • BACFormer: A robust boundary-aware transformer for medical image segmentation

    by Zhiyong Huang, Mingyu Wang, Mingyang Hou, Zhi Yu, Shiwei Wang, Xiaoyu Li, Jiahong Wang, Yan Yan, Yushi Liu


  • Overcoming Limitations in One-Shot Semantic Segmentation via Adaptive Visual-Text Guided Prototype Relationship Optimization

    by Mingyang Hou, Zhiyong Huang, Zhi Yu, Xiaoyu Li, Jiahong Wang, Yan Yan, Yushi Liu, Hans Gregersen

    The scarcity of high-quality annotated data in medical imaging significantly constrains the performance of deep learning-based segmentation models. While few-shot medical image segmentation (FSMIS) has emerged as a promising solution, existing methods exhibit critical limitations when handling scenarios with inter-class similarity between foreground-background regions and intra-class heterogeneity within foreground objects. Current prototype-based approaches focus primarily on the holistic extraction of the prototype from support images, failing to distinguish subtle anatomical variations and complex feature representations effectively. The AVT-ProNet features three innovative components: 1) An Adaptive Visual-Text Prototype Generation (AVPG) module leveraging CLIP’s cross-modal guide capabilities through adaptive prompting strategies; 2) a graph-based multiregion prototyping relationship optimization (GMPRO) module establishing structural relationships between decomposed subregion prototypes via graph neural networks; 3) a foreground-background prototyping contrast learning (FBPCL) strategy implementing dual-space optimization through inter-class separation and intra-class compactness. The synergistic integration of multi-modal guidance, structural relationship modeling, and contrastive prototype refinement enables our framework to overcome existing limitations in FSMIS. Comprehensive evaluations across multiple clinical scenarios (CHAOS, SABS, and CMR datasets under diverse training configurations) demonstrate superior performance over state-of-the-art approaches, including PANet, CAT-Net, DMAP, and recent PAMI baselines, Source code is available at https://github.com/394481125/AVT-ProNet.

  • Open Access

    Medically-Constrained Gradient Boosting for Predicting Blood Transfusion Need and Dose in Upper Gastrointestinal Bleeding (Preprint)

    by Xiaoyu Li, Yuqin He, Mingyang Hou, Zhi Yu, Shuai Miao, Zhiyong Huang, Min Yang

    BACKGROUND Transfusion thresholds in upper gastrointestinal bleeding (UGIB) are debated; hemoglobin cutoffs of 70–80 g/L are widely cited yet inconsistently applied. Common risk scores offer limited individualized guidance and rarely provide calibrated, interpretable predictions for transfusion decisions. OBJECTIVE To develop and validate a two-stage, clinically constrained gradient-boosting framework (Medically-Constrained Gradient Boosting, MGCB) that predicts transfusion need and estimates transfusion dose with quantified uncertainty, and to implement a prototype recommendation system for clinical use. METHODS We analyzed a retrospective multicenter cohort of 849 adults with endoscopically confirmed UGIB admitted to three hospitals in Chongqing, China (January 2019–August 2025). Predictors available before the transfusion decision included demographics, first recorded vital signs, initial laboratory indices, and clinician-adjudicated etiology. Stage 1 used a calibrated classifier with prespecified monotonic constraints and stability-screened, clinically justified interactions. Stage 2 modeled transfusion dose via quantile predictions with conformal adjustment to generate 95% prediction intervals. Performance was assessed using stratified five-fold cross-validation with discrimination (AUROC, AUPRC), calibration metrics and decision-curve analysis; regression performance included R², mean absolute error (MAE), and prediction-interval coverage. A graphical user interface was implemented to allow clinician input of patient data and to return calibrated transfusion probabilities and dose recommendations. RESULTS MGCB achieved strong discrimination and good calibration across subgroups (AUROC 0.97; AUPRC 0.91). At a probability threshold of 0.50, sensitivity, specificity, and F1 score were 0.99, 0.87, and 0.85, respectively. For dose prediction among transfused patients, MGCB achieved R² 0.95 and MAE 0.04; 95% prediction-interval coverage was 0.94, indicating accurate point estimates with reliable uncertainty quantification. The software prototype further demonstrated feasibility of real-time decision support at the bedside. CONCLUSIONS MGCB provides calibrated, interpretable predictions of transfusion need and individualized dose in UGIB and may support bedside decision-making and blood-bank planning, with a prototype interface demonstrating potential for clinical deployment. External validation in additional settings is warranted to confirm generalizability. CLINICALTRIAL Not applicable. This study does not involve a registered clinical trial or systematic review.